The FDA has released a draft of new guidance addressing common FAQs about the development of potential CGT treatments.

Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.

The upcoming clinical trial conferences will host talks on supply chain resilience, AI’s growing role and forging industry ...

Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance ...

EMA's CHMP has recommended AstraZeneca's Tagrisso for approval in the European Union to treat individuals with NSCLC.

ReCode is set to secure up to $15m in funding from the Cystic Fibrosis Foundation to enhance its gene correction research ...

Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist ...

Robert F Kennedy Jr (pictured) will head the Department of Health and Human Services (HHS). Image credit: Shutterstock / ...

At the American Heart Association’s (AHA) 2024 Annual Scientific Sessions, which took place from 16 November to 18 November ...

DMD is a rare, progressive genetic disorder characterised by the degeneration and weakness of muscles. Credit: Raja GamerXTC ...

The US FDA has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating acute leukaemia with KMT2A translocation.

AstraZeneca has selected a candidate to progress in the type 1 diabetes (T1D) Treg cell therapy programme, as per an 18 ...